ArticleFrontiers in veterinary science2026
Microscopic and computational analysis of the stomach, duodenum, and liver of rats with induced hyperprolactinemia treated with exogenous melatonin.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study evaluated the effects of exogenous melatonin (MEL) on morphological and computational alterations in the stomach, duodenum, and liver of hyperprolactinemic rats. Methods: Twenty-four animals were divided into three groups: Control ( Results: The Hyper group showed a higher body weight compared to the Control group, while both hyperprolactinemic groups exhibited gastric lumen dilation. PCNA immunolabeling increased in the liver and, to a lesser extent, in the stomach, while decreasing in the duodenum in the Hyper and Hyper+MEL groups. In the duodenum, both hyperprolactinemic groups exhibited increased villus and microvillus height, whereas a reduced Periodic Acid-Schiff (PAS)-stained area was detected only in the Hyper group. In the liver, microsteatosis, fewer Kupffer cells (KCs), and a higher number of binucleated hepatocytes were identified in hyperprolactinemic animals. Fractal analysis of goblet cells revealed no differences among groups. Serum MEL levels were elevated in the hyperprolactinemic groups, with the highest concentrations observed in the Hyper+MEL group. Discussion: In summary, hyperprolactinemia induced structural alterations in the stomach, duodenum, and liver, whereas MEL administration exerted limited effects, mainly influencing body weight and duodenal histochemical parameters, without consistent protective effects on the other evaluated outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.